《生物調(diào)節(jié)劑和靜電劑雜志》審議了在生物反應(yīng)調(diào)節(jié)劑和靜電劑領(lǐng)域發(fā)表經(jīng)同行評(píng)審的原始貢獻(xiàn)、評(píng)論和社論。該期刊涵蓋的領(lǐng)域?qū)ㄒ韵路矫娴幕A(chǔ)和臨床研究：分子生物學(xué)；藥理學(xué)；細(xì)胞生理學(xué)；免疫療法；免疫學(xué)；移植；（淋巴激素和干擾素）；預(yù)防醫(yī)學(xué)；內(nèi)分泌；流式細(xì)胞術(shù)；珠陣技術(shù)；細(xì)胞學(xué)。所有可能導(dǎo)致細(xì)胞調(diào)節(jié)或分化的物質(zhì)或藥物都將包括在期刊的主題中。當(dāng)然，對(duì)遺傳工程方法及其產(chǎn)品的研究也引起了編輯們的濃厚興趣。最近的分子和細(xì)胞生物學(xué)革命所產(chǎn)生的新的和有前途的抗癌和抗病毒戰(zhàn)略將為加強(qiáng)科學(xué)知識(shí)和討論提供新的機(jī)會(huì)。新的臨床細(xì)胞分析部分涵蓋了用于臨床目的的細(xì)胞分析的技術(shù)和檢驗(yàn)的進(jìn)步和標(biāo)準(zhǔn)化。

The Journal of Biological Regulators and Homeostatic Agents considers the publication of peer-reviewed original contributions, reviews and editorials in the field of biological response regulators and homeostatic agents. The areas covered by the Journal will include basic and clinical research on: molecular biology; pharmacology; cell physiology; immunotherapy; immunology; transplantation; (lymphokines and interferons); preventive medicine; endocrinology; flow cytometry; bead array technology; cytomics. All substances or drugs that could be responsible for cellular regulation or differentiation will range among the topics of the Journal. Of course, research on genetic engineering methods and their products also have the vivid interest of the Editors. The new and promising anti cancer and anti virus strategies resulting from the recent revolution in molecular and cellular biology will provide new opportunities for enhancing scientific knowledge and discussion. The new section on Clinical Cell Analysis covers the advancement and standardization of techniques and assays used for cell analysis for clinical purposes.